trial

Cognitive Remediation Therapy in Schizophrenia: Effects on Epigenetics

NCTId NCT04278027
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 60 (actual)
Sponsored by Hospital Clinic of Barcelona
Primary completion 2020-05-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
60 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2017-01-03
Primary completion
2020-05-05
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Cognitive Remediation Therapy

Sponsors

Hospital Clinic of BarcelonaLead Sponsor
National Alliance for Research on Schizophrenia and DepressionCollaborator
Instituto de Salud Carlos IIICollaborator

Investigators

1
Rafael Penadés, PhDPrincipal Investigator

Sites

1 total
Barcelona, Spain

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2020-05-05
Status
UNKNOWN
relationships
The graph out of here
drug
Cognitive Remediation Therapy
drug
lead_sponsor
Hospital Clinic of Barcelona
company
collaborator
National Alliance for Research on Schizophrenia and Depression
company
Instituto de Salud Carlos III
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Rafael Penadés, PhD
person